Understanding how cognitive abilities affect movement in older adults

Analysis of Motor Skills in Subjects Aged 55 and Over: the Role of Cognitive Abilities for Planning Movement.

Observational Centre Hospitalier Universitaire Dijon · NCT04754906

This study looks at how thinking skills affect movement in older adults over 55, especially those with mild cognitive issues, to see if it can help prevent falls.

Quick facts

Study typeObservational
Enrollment684 (estimated)
Ages18 Years and up
SexAll
SponsorCentre Hospitalier Universitaire Dijon Academic / other
Locations1 site (Dijon)
Trial IDNCT04754906 on ClinicalTrials.gov

What this trial studies

This observational study aims to analyze the relationship between cognitive abilities and motor skills in individuals aged 55 and over, particularly focusing on those with mild cognitive disorder. By examining how cognitive decline influences movement planning and execution, the research seeks to shed light on the increased risk of falls in the elderly population. The findings could lead to improved strategies for fall prevention and rehabilitation in older adults. Participants will be assessed based on their cognitive and motor skills through various tests.

Who should consider this trial

Good fit: Ideal candidates include individuals aged 55 and over, both neurotypical and those diagnosed with mild cognitive disorder.

Not a fit: Patients under 55 years of age or those with significant cognitive impairments may not benefit from this study.

Why it matters

Potential benefit: If successful, this study could enhance fall prevention strategies and improve the quality of life for older adults.

How similar studies have performed: While there is ongoing research into the links between cognitive decline and motor skills, this specific approach focusing on older adults with mild cognitive disorder is relatively novel.

Eligibility criteria

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Neurotypical subjects group:

   * Person aged 18 to 40 years
   * Person who has given oral consent
   * Affiliated to national health insurance
   * Right-handed person
2. Group of elderly neurotypical subjects:

   * Person over 55 years of age
   * Person who has given oral consent
   * Affiliated to national health insurance
   * No cognitive problems (MMSE score \>26)
   * Right-handed person
3. Elderly mild cognitive disorder subject group:

   * Person over 55 years of age
   * Person who has given oral consent
   * Diagnosis of Mild Cognitive Disorder made by a neurologist at the Centre Mémoire Ressources et Recherche (CMRR) of the University Hospital of Dijon, following the recommendations of the National Institute for Aging and Alzheimer's Association (Albert et al., 2011) This diagnosis is based on psychometric tests, brain imaging and the evolution of cognitive disorders, including an MMSE test.
   * Right-handed person

Exclusion Criteria:

* Neurological or psychiatric history with the exception of the TCL group.
* Follow-up of drug treatment in the last three months that may affect cognitive and/or motor skills.
* Received a shoulder prosthesis on the dominant side.
* Received a hip and/or knee replacement less than a year ago.
* Disabling joint disease of the hip or knee shoulder
* Protected adults (curatorship, guardianship)
* Person deprived of their liberty b judicial or administrative decision
* Pregnant, parturient or breastfeeding woman
* Major unable to consent

Where this trial is running

Dijon

Study contacts

How to participate

  1. Review the eligibility criteria above with your treating physician.
  2. Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
  3. Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions Mild Cognitive Disorder
Last reviewed 2026-06-09 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.